Scope

Aims and Scope: The Journal of Angiotherapy (JoA) is an international, peer-reviewed, open-access journal dedicated to advancing the field of biomedical, medicine, public health,  disease mechanisms, health Interventions, clinical & translational research, biochemistry and integrative biological sciences, molecular biology, drug delivery, and drug discovery. As a multidisciplinary platform, JoA bridges various fields of biomedical and biological sciences, offering a comprehensive exploration of mechanisms and interventions. JoA serves as a dynamic platform for researchers, clinicians, and scientists to explore the complexities of inflammation, diseases, and health interventions.

JoA welcomes the submission of original research articles, reviews, data reports, case studies, clinical trials, and brief communications that present significant, novel findings and advance knowledge within the realm of integartive biomedical research areas.

All accepted manuscripts are published continuously and made freely available online immediately upon publication. This open-access model ensures unrestricted access to research, facilitating widespread dissemination and engagement within the scientific community.

JoA is committed to being a valuable resource for researchers, scientists, and clinicians aiming to expand the boundaries of knowledge in integrative fields.

Peer-Review Process (please see detials in peer review policy and publishing policies)

The journal is committed to publishing research works by utilizing a rapid, impartial, and rigorous review process. All submitted papers are subjected to strict single-blind peer review by its distinguished international Advisory Board members, as well as by other anonymous international and national reviewers. Submitted manuscripts must not have been published previously in any copyright form (print or electronic/online).

The journal is committed to publishing research works by utilizing a rapid, impartial, and rigorous review process. All submitted papers are subjected to strict single blind peer review by its distinguished international Advisory Board members, as well as by other anonymous international and national reviewers. Submitted manuscripts must not have been published previously in any copyright form (print or electronic/online).

The general criteria for acceptance of a manuscript are:

• advances scientific knowledge;

• advances translational research;

• provides an adequate and relevant literature review;

• utilizes scientifically solid, reliable, and reproducible methodologies;

• derives appropriate and justifiable conclusions based upon the experimental data presented; and

• is written in English and is of the utmost quality and clarity.

JoA will facilitate the author's response to the NIH Public Access Policy.